Login / Signup

Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South Korea.

Jun Yong ChoiJin Ok OhJin Young AhnHeun ChoiJeong Ho KimHye SeongSu Jin JeongNam Su KuJoon Sup YeomJae Phil Choi
Published in: Clinical and experimental vaccine research (2019)
We evaluated the neutralizing activity in serum from three patients >1 year after recovery from Middle East respiratory syndrome (MERS) associated with mild pneumonia treated with antivirals during the MERS outbreak in South Korea at 2015. The neutralizing activity in serum was measured by pseudovirus inhibition assays. Three-fold diluted serum of subjects showed only 9.7%, 10.3%, and 2.2% reductions in relative light units. So, significant neutralizing activity was not demonstrated in any sera of three patients with mild pneumonia >1 year after being successfully treated with antiviral agents and recovering from MERS coronavirus infection.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • dengue virus
  • end stage renal disease
  • chronic kidney disease
  • zika virus
  • intensive care unit
  • peritoneal dialysis
  • patient reported outcomes